fbpx

OVERVIEW

As healthcare systems evolve, Pharmacoeconomics will remain a key discipline for guiding decisions that optimize outcomes, resource allocation, and the overall sustainability of healthcare.

This Summit has been meticulously crafted to serve as a dynamic platform for thought leaders, policymakers, and key stakeholders to exchange insights, share experiences, in the areas focused on healthcare policy, the HEOR in healthcare decision making, economic evaluations, VBHC, the implications of HTA, responses to Real-World Evidence, collaboration, affordability, and equity in healthcare, that enhance patient outcomes, ensure accessibility to innovative therapies, and contribute to the sustainability of our healthcare infrastructure.

WHO SHOULD ATTEND

  • Regulatory authorities
  • Pharmacoeconomists
  • Health Economists
  • Health Technology Assessment Specialists
  • Payers
  • Healthcare providers
  • Pharma industry
  • Pharmacists and more

KEY BENEFITS OF ATTENDING

  • Highlight future opportunities and challenges in developing the healthcare and research economy in the GCC countries
  • Discuss the novel approaches to value assessment, achieving cost effective healthcare solutions and access to innovative medicines in the GCC
  • Understanding the principles of outcome based healthcare and evidence based medication
  • Reviewing pharmacoeconomics and outcomes research strategies
  • Exploring the real world data, the burden of disease and HTA to make proper assessments and support decision making

Summit Chairman

Ahmed Al Jedai
Ahmed Al Jedai

Pharm.D., M.B.A., BCPS, FCCP, FAST, FCCP, FASHP, Founding President, Saudi Society of Clinical Pharmacy (SSCP), Professor, Colleges of Medicine and Pharmacy, Alfaisal University, Consultant Clinical Pharmacist, Solid Organ Transplant, King Faisal Specialist Hospital & Research Centre, KSA

Scientific Committee Chair 

Hajer Al-Mudaiheem
Hajer Al-Mudaiheem

Pharm.D., MSc. Clinical pharmacy, CLSSBB Advisor, Assistant Deputy for Therapeutic Supportive Services, Director, Drug Policy and Regulation Department Ministry of Health, KSA

Summit Packages

2-Days Summit Access

Physicians, Regulatory Authorities, Health Economists, Hospital and Community Pharmacists

Pharmaceutical Companies and Vendors

for Group Registration

Please contact: +971 4 361 9616

Scientific Committee Members

Ahmed Al Jedai
Ahmed Al Jedai

Pharm.D., M.B.A., BCPS, FCCP, FAST, FCCP, FASHP, Founding President, Saudi Society of Clinical Pharmacy (SSCP), Professor, Colleges of Medicine and Pharmacy, Alfaisal University, Consultant Clinical Pharmacist, Solid Organ Transplant, King Faisal Specialist Hospital & Research Centre, KSA

Anas Hamad
Anas Hamad

PhD, MSc, DMS, BPharm, RPh, Director of Pharmacy Department, National Center for Cancer Care & Research NCCCR, Qatar

Fabrizio Gianfrate
Fabrizio Gianfrate

Full Professor of Health Economics and Outcome Research, University of Ferrara and LUISS Business School Rome, Italy

Hajer Al-Mudaiheem
Hajer Al-Mudaiheem

Pharm.D., MSc. Clinical pharmacy, CLSSBB Advisor, Assistant Deputy for Therapeutic Supportive Services, Director, Drug Policy and Regulation Department Ministry of Health, KSA

Maryam Alowayesh
Maryam Alowayesh

PhD, MSc, Assistant Professor, School of Pharmacy, College of Pharmacy – Kuwait University, President, ISPOR Kuwait Chapter, Kuwait

Mouna Jameleddine
Mouna Jameleddine

Director, Health Technology Assessment Department, National
Authority for Assessment and Accreditation in Healthcare (INEAS), Tunisia

Sara Al Dallal
Sara Al Dallal

MBBS, MSc, President, Emirates Health
Economics Society, Emirates Medical Association; Senior Health Service Specialist, Dubai Health Authority, UAE